Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYılmaz, İIhanen_US
dc.contributor.authorErdogan, Uzayen_US
dc.contributor.authorTanrıverdi, Osmanen_US
dc.contributor.authorGünaldı, Ömüren_US
dc.contributor.authorAdilay, Hüseyin Utkuen_US
dc.contributor.authorÖmeroğlu, Muhammeden_US
dc.contributor.authorTanık, Cananen_US
dc.contributor.authorTuğcu, Bekiren_US
dc.date.accessioned2022-07-04T08:40:40Z
dc.date.available2022-07-04T08:40:40Z
dc.date.issued2021en_US
dc.identifier.issn1019-5149
dc.identifier.urihttps://doi.org/10.5137/1019-5149.JTN.30259-20.2
dc.identifier.urihttps://hdl.handle.net/20.500.12462/12382
dc.descriptionAdilay, Hüseyin Utku (Balikesir Author)en_US
dc.description.abstractAs the authors of the paper titled “Evaluation of Bevacizumab for the Treatment of Epidural Fibrosis by Immunohistochemical Staining for CD105 and Osteopontin” published in 2018, Volume 28(6), pp. 954–962,en_US
dc.language.isoengen_US
dc.publisherTurkish Neurosurgical Socen_US
dc.relation.isversionof10.5137/1019-5149.JTN.30259-20.2en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectNeurosciences & Neurologyen_US
dc.subjectSurgeryen_US
dc.titleInadvertent Error: Evaluation of Bevacizumab for the Treatment of Epidural Fibrosis by Immunohistochemical Staining for CD105 and Osteopontinen_US
dc.typeletteren_US
dc.relation.journalTurkish Neurosurgeryen_US
dc.identifier.volume31en_US
dc.identifier.issue1en_US
dc.identifier.startpage149en_US
dc.identifier.endpage150en_US
dc.relation.publicationcategoryDiğeren_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster